Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02578862Phase 4Completed
Phase 4, randomised, double-blind trial of propofol in chronic rhinosinusitis (CRS) (2 arms), sponsored by Ochsner Clinic Foundation. Primary endpoint: Intraoperative Visual Field Assessment. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02578862.